keyword
https://read.qxmd.com/read/38650545/paediatric-cutaneous-lymphomas-including-rare-subtypes-a-40-year-experience-at-a-tertiary-referral-centre
#1
JOURNAL ARTICLE
Silvia Alberti-Violetti, Gianluca Avallone, Cristiana Colonna, Gianluca Tavoletti, Luigia Venegoni, Valentina Merlo, Stefano Cambiaghi, Angelo V Marzano, Emilio Berti, Riccardo Cavalli
BACKGROUND: Primary cutaneous lymphomas are neoplasms of the immune system with a distinct tropism for the skin and an absence of extracutaneous manifestations at the time of diagnosis. Studies focusing on cutaneous lymphomas in children and adolescents remain scarce and often do not encompass the rare subtypes. OBJECTIVES: To address this knowledge gap by describing the clinical, histological and molecular characteristics of a large group of paediatric patients affected by primary cutaneous lymphoma...
April 23, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38581201/classifications-of-cutaneous-lymphomas-and-lymphoproliferative-disorders-an-update-from-the-eortc-cutaneous-lymphoma-histopathology-group
#2
REVIEW
W Kempf, C Mitteldorf, L Cerroni, R Willemze, E Berti, E Guenova, J J Scarisbrick, M Battistella
The classification of primary cutaneous lymphomas and lymphoproliferative disorders (LPD) is continuously evolving by integrating novel clinical, pathological and molecular data. Recently two new classifications for haematological malignancies including entities of cutaneous lymphomas were proposed: the 5th edition of the WHO classification of haematolymphoid tumours and the International Consensus Classification (ICC) of mature lymphoid neoplasms. This article provides an overview of the changes introduced in these two classifications compared to the previous WHO classification...
April 6, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38499969/cutaneous-lymphoproliferative-disorders-back-to-the-future
#3
REVIEW
Rein Willemze
In the 1980s, immunohistochemistry and clonality analyses became instrumental in the recognition and definition of new types of cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL) and the development of new classifications. By accepting loss of pan-T-cell antigens and clonal T-cell receptor gene rearrangements as important criteria to differentiate between benign and malignant T-cell proliferations, and monotypic immunoglobulin light-chain expression and clonal immunoglobulin gene rearrangements as crucial criteria to distinguish between benign and malignant B-cell proliferations, many cases, until then diagnosed as cutaneous lymphoid hyperplasia or pseudolymphoma, were reclassified as primary cutaneous CD4+ small/medium T-cell lymphoma (PCSM-TCL) or primary cutaneous marginal zone lymphoma (PCMZL), respectively...
March 18, 2024: Journal of Cutaneous Pathology
https://read.qxmd.com/read/38473391/a-descriptive-study-of-103-primary-cutaneous-b-cell-lymphomas-clinical-and-pathological-characteristics-and-treatment-from-the-spanish-lymphoma-oncology-group-gotel
#4
JOURNAL ARTICLE
Natividad Martínez-Banaclocha, Francisca Martínez-Madueño, Berta Caballé, Joan Badia, Mar Blanes, David Aguiar Bujanda, Virginia Calvo, Jose Gómez Codina, Cristina Quero Blanco, Pablo Espinosa, Javier Lavernia, Francisco Ramón García Arroyo, María Guirado Risueño, Cristina Llorca, Raquel Cumeras, Mariano Provencio Pulla, Josep Gumà
Primary cutaneous B-cell lymphomas (PCBCLs) are B-cell lymphomas that can occur in the skin without evidence of extracutaneous involvement. The 2005 WHO/EORTC classification of cutaneous lymphomas and its 2018 update have distinguished three main categories based on clinicopathological, immunohistochemical, and genetic characteristics: primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle centre lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT)...
March 3, 2024: Cancers
https://read.qxmd.com/read/38322474/marginal-zone-lymphoma-with-severe-rashes-a-case-report
#5
Si-Jun Bai, Ye Geng, Yi-Nan Gao, Cai-Xia Zhang, Qian Mi, Chen Zhang, Jia-Ling Yang, Si-Jie He, Zhen-Ying Yan, Jian-Xia He
BACKGROUND: Marginal zone lymphoma (MZL) is an indolent subtype of non-Hodgkin lymphoma (NHL), which is rare clinically with severe rashes as the initial symptom. CASE SUMMARY: This study reports a case of MZL with generalized skin rashes accompanied by pruritus and purulent discharge. First-line treatment with rituximab combined with zanubrutinib had poor effects. However, after switching to obinutuzumab combined with zanubrutinib, the case was alleviated, and the rashes disappeared...
January 26, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38279594/health-related-quality-of-life-and-its-influencing-factors-in-patients-with-primary-cutaneous-b-cell-lymphomas-a-multicentric-study-in-100-patients
#6
JOURNAL ARTICLE
A E C Schirren, J D Albrecht, S Melchers, C Weiß, S Büttner, E Dippel, J Gosmann, C Jonak, C-D Klemke, M Laturnus-Chang, E Livingstone, C Mitteldorf, P Schummer, R Stadler, R Stranzenbach, S S Weyer-Fahlbusch, M Wobser, M Ziemer, J P Nicolay
BACKGROUND: Primary cutaneous B-cell lymphomas (CBCL) are a group of rare malignant skin diseases that represent approximately 20%-30% of all primary cutaneous lymphomas (PCL). Previous studies revealed impaired health-related quality of life (HRQoL) in patients diagnosed with primary cutaneous T-cell lymphoma (CTCL). Currently, only small-sized studies investigated HRQoL in CBCL patients and lacked detailed analysis of respective subtypes. OBJECTIVES: This study aims to investigate HRQoL in CBCL patients to identify independent factors of HRQoL impairment in CBCL patients...
January 26, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38152012/a-patient-with-widespread-skin-lesions-presenting-with-massive-pleural-effusion
#7
JOURNAL ARTICLE
Aslıhan Gürün Kaya, Pervin Topçuoğlu, Ayten Kayı Cangır, Nihal Kundakçı, Işınsu Kuzu, Aylin Okçu Heper, Demet Karnak
Mycosis fungoides is the most commonly seen type of cutaneous T-cell lymphoproliferative disease. While mycosis fungoides is linked to an increased risk of developing secondary malignancies, the occurrence of B-cell-originated disease in association with it is exceedingly rare. A 66-year-old male with persistent papillomatous skin eruption was admitted due to dyspnea. Chest X-ray, positron emission tomography, and chest computed tomography revealed axillary and mediastinal lymph node enlargement and right lower pulmonary lobe infiltration along with right-sided massive pleural effusion...
December 2023: Tüberküloz Ve Toraks
https://read.qxmd.com/read/38091439/pediatric-primary-cutaneous-marginal-zone-lymphoma-treated-with-doxycycline
#8
JOURNAL ARTICLE
Grace C Chan, Sonia Kamath
Primary cutaneous marginal zone lymphoma (PCMZL) is a cutaneous B-cell lymphoma that rarely occurs in children. We present a 13-year-old boy with multiple asymptomatic erythematous papules and nodules on the trunk and arms that were confirmed on biopsy to be PCMZL. He was treated with doxycycline and intralesional triamcinolone with improvement of lesions. This case supports the use of doxycycline for the treatment of pediatric PCMZL in patients with widespread involvement despite negative Borrelia serology...
November 2023: Cutis; Cutaneous Medicine for the Practitioner
https://read.qxmd.com/read/38061732/occurence-of-cutaneous-marginal-zone-b-cell-lymphoma-post-breast-cancer-chemotherapy-a-case-report
#9
Ji-Hoon Lim, Soon-Hyo Kwon, Woo-Young Sim, Bark-Lynn Lew
Primary cutaneous marginal zone B-cell lymphomas (PCMZLs) are classified as low-grade as they run an indolent course. They are histologically characterized through non-epidermotropic nodular or diffuse infiltrates consisting of small or medium heterogeneous atypical lymphoid cells. In the past few years, chemotherapy has increased the survival rate of breast cancer patients. However, the adverse effects of treatment, such as leukemia, have also been shown to emerge gradually. Additionally, cases of occurrence of non-Hodgkin lymphoma (NHL) post chemotherapy have also been reported...
November 2023: Annals of Dermatology
https://read.qxmd.com/read/38018231/primary-cutaneous-marginal-zone-lymphoproliferative-disorder-following-covid-19-vaccination
#10
Carla Stephan, Paul Barone, Jeanyoung Kim, Linglei Ma
During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccines were administered worldwide. A number of skin reactions, including primary cutaneous T-cell lymphoproliferative disorders (LPDs) were reported following COVID-19 vaccination. We report a case of primary cutaneous marginal zone lymphoproliferative disorder (PCMZLPD) secondary to COVID-19 vaccination. A 57-year-old man presented with an erythematous nodule on his left arm at the site of vaccine inoculation following his first dose of the Moderna (mRNA-1273) vaccine a few weeks prior...
November 28, 2023: Journal of Cutaneous Pathology
https://read.qxmd.com/read/37999132/characteristics-of-primary-cutaneous-lymphoma-in-italy-a-tertiary-care-single-center-study
#11
JOURNAL ARTICLE
Martina D'Onghia, Alessandra Cartocci, Laura Calabrese, Daniele Maio, Azzurra Sirchio, Maria Erasti, Linda Tognetti, Pietro Rubegni, Monica Bocchia, Emanuele Cencini, Alberto Fabbri, Elisa Cinotti
Data on primary cutaneous lymphomas (PCLs) patients in the Italian population are limited, and, despite the existence of several treatment options, the management of those patients remains challenging. Our study aimed to investigate the clinical and therapeutic features of PCL patients in a referral center in Italy. We conducted a retrospective study on 100 consecutive PCL patients between January 2017 and December 2022. The mean (SD) age of our cohort was 70.33 (14.14) years. Cutaneous T-cell lymphomas (CTCLs) represented 65% of all cases; the majority were mycosis fungoides (42%), followed by cases of Sezary syndrome (10%) and primary cutaneous anaplastic large cell lymphoma (4%)...
November 8, 2023: Current Oncology
https://read.qxmd.com/read/37988030/tissue-eosinophilia-in-b-cell-lymphoma-an-underrecognized-phenomenon
#12
JOURNAL ARTICLE
Ting Zhou, Hao Wei Wang, Siok Bian Ng, Thomas Summers, Liqiang Xi, Mark Raffeld, Stefania Pittaluga, Elaine S Jaffe
Tissue eosinophilia is seldom reported in B-cell lymphoma. It poses diagnostic challenges and frequently leads to the consideration of other diagnoses, particularly T-cell lymphomas. The scarce literature underscores the need for in-depth studies to enhance awareness and understanding of this phenomenon. We investigated 54 cases of B-cell lymphoma with notable tissue eosinophils, analyzing clinical information, hematoxylin and eosin staining, immunohistochemistry, and PCR-based clonality analysis. Nodal marginal zone lymphoma (NMZL) emerged as the most prevalent type (n=26), followed by B-cell lymphoma, not otherwise specified (n=13), diffuse large B-cell lymphoma (n=10), follicular lymphoma (n=2), chronic lymphocytic leukemia/small lymphocytic lymphoma (n=1), extranodal marginal zone lymphoma (n=1), and primary cutaneous marginal zone lymphoma (n=1)...
November 21, 2023: American Journal of Surgical Pathology
https://read.qxmd.com/read/37899942/primary-cutaneous-marginal-zone-lymphoma-following-repeated-inflammation-caused-by-hair-dyeing
#13
Jun Hyo Lee, Ui Hyeon Jo, Tae Min Kim, Dae Hun Suh
Primary cutaneous marginal zone lymphoma (PCMZL) is a rare form of B-cell lymphoma that primarily affects the skin. Chronic antigen stimulation has been implicated in its development, with cases associated with various triggers. We present a case of PCMZL following chronic inflammation caused by long-term hair dyeing. A 75-year-old woman with a history of repeated inflammation and itching after hair dyeing for 30 years presented with persistent red-to-violaceous patches and plaques on her scalp. Despite receiving topical corticosteroid treatment for 10 years, the lesions remained...
2023: Case Reports in Dermatology
https://read.qxmd.com/read/37853944/assessment-of-specificity-of-dermatopathologic-criteria-for-igg4-related-skin-disease
#14
JOURNAL ARTICLE
Zachary Skopec, Mouaz Alsawas, Timothy Maxwell, Daniel Pelletier, Zoe Brown-Joel, Andrew Bellizzi, Vincent Liu
BACKGROUND: IgG4-related disease (IgG4-RD) represents a recently characterized multisystemic fibroinflammatory condition that can manifest a spectrum of skin findings (IgG4-related skin disease; IgG4-RSD). Histopathologic and immunohistochemical criteria have been proposed; however, the specificity of these criteria merits scrutiny given the potential histopathologic overlap of IgG4-RSD and both neoplastic and inflammatory skin conditions featuring lymphoplasmacytic infiltrates (IgG4-RSD mimics)...
October 18, 2023: Journal of Cutaneous Pathology
https://read.qxmd.com/read/37838228/-not-available
#15
P J Gómez Arias, Sofía Vázquez Díaz, Alicia Sanz Zorrilla, Beatriz Baleato Gómez
No abstract text is available yet for this article.
October 12, 2023: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/37701886/sequential-primary-cutaneous-follicle-center-lymphoma-and-marginal-zone-b-cell-lymphoma-arising-in-the-same-patient
#16
Gabriella Alvarez, Larissa Rodriguez-Homs, Rami N Al-Rohil, Meenal Kheterpal, Amber Fresco
No abstract text is available yet for this article.
October 2023: JAAD Case Reports
https://read.qxmd.com/read/37683801/-not-available
#17
P J Gómez Arias, Sofía Vázquez Díaz, Alicia Sanz Zorrilla, Beatriz Baleato Gómez
No abstract text is available yet for this article.
September 6, 2023: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/37640411/primary-cutaneous-marginal-zone-lymphoma-presenting-with-secondary-chilblains-of-the-toes
#18
JOURNAL ARTICLE
Ali Zagham Nasir, Ryan Scott Burmeister
Cutaneous lymphoproliferative disorders include cutaneous manifestations of systemic B-cell or T-cell lymphoma and primary cutaneous lymphomas. Primary cutaneous B-cell lymphomas are subcategorised into four groups: primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle centre lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg-type and EBV-positive mucocutaneous tumour. Each of these cutaneous lymphoproliferative disorders has unique clinical and pathological features necessitating biopsy and staging to establish proper treatment...
August 27, 2023: BMJ Case Reports
https://read.qxmd.com/read/37573681/intracranial-hematolymphoid-malignancies-a-case-series-with-molecular-characterization
#19
JOURNAL ARTICLE
Rebekah G Langston, Heather Pinckard-Dover, Grace Guzman, Christopher P Wardell, Murat Gokden, T W Morris, J D Day, Analiz Rodriguez
OBJECTIVE: Central nervous system (CNS) manifestations of hematologic malignancies are uncommon and often have a poor prognosis. As hematologic neoplasms are typically chemotherapy- and radiotherapy-sensitive, surgical resection is usually not indicated; thus, opportunities for in-depth characterization of CNS hematologic tumors are limited. Here, we report four cases of rare intracranial hematologic tumors requiring surgical intervention, allowing for histopathologic and genomic characterization...
August 4, 2023: Clinical Neurology and Neurosurgery
https://read.qxmd.com/read/37434388/cutaneous-b-cell-lymphomas-2023-update-on-diagnosis-risk-stratification-and-management
#20
JOURNAL ARTICLE
Alexandra C Hristov, Trilokraj Tejasvi, Ryan A Wilcox
DISEASE OVERVIEW: Approximately one-fourth of primary cutaneous lymphomas are B-cell derived and are generally classified into three distinct subgroups: primary cutaneous follicle center lymphoma (PCFCL), primary cutaneous marginal zone lymphoma (PCMZL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT). DIAGNOSIS: Diagnosis and disease classification is based on histopathologic review and immunohistochemical staining of an appropriate skin biopsy...
August 2023: American Journal of Hematology
keyword
keyword
17268
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.